Tirzepatide 30mg
- Purity (HPLC)
- 99.2%
- Net peptide content
- 28.2 mg
- Batch
- TI-26130
For research use only. Not for human or veterinary use. Product information describes molecules and published research and is not medical advice or a protocol.
- ~3 day US delivery
- 99%+ purity tests
- Ships from Arizona
- USA lab tested
Description
Tirzepatide is a synthetic 39-amino-acid peptide designed as a dual incretin receptor agonist. Its sequence is built on the native GIP backbone with engineered substitutions, including non-standard residues that resist enzymatic degradation. It acts as a co-agonist at the GIP and GLP-1 receptors, two class B G-protein-coupled receptors that drive cyclic-AMP and related intracellular signaling.
Tirzepatide is an extensively characterized molecule in the peer-reviewed literature, where it has been studied in the context of glucose metabolism, incretin receptor pharmacology, and metabolic signaling. A C20 fatty-diacid moiety supports albumin binding and a prolonged half-life. Signal supplies it as a research-grade reference material, tested by HPLC and mass spectrometry on every batch.
Key Characteristics
Molecular Profile
Formula: C225H348N48O68
Weight: 4813.5 g/mol
CAS: 2023788-19-2
Structure: 39-amino-acid synthetic peptide, lipidated dual agonist
Physical Properties
Form: White to off-white lyophilized powder
Solubility: Soluble in water and bacteriostatic water
Natural Occurrence: Does not occur naturally; engineered from the GIP hormone
Storage: Store lyophilized, protected from light. Refrigerate 36-46 °F (2-8 °C) or freeze for long-term storage